(Q72331601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

Pancras C.W. Hogendoorn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

H C Holscher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J L Bloem

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

H J van der Woude

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J Hermans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M A Nooy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A H Taminiau

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

384-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Osteosarcoma: chemotherapy-induced changes at MR imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Extremity osteosarcoma in childhood: prognostic value of radiologic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Osteosarcoma: MR imaging after preoperative chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Osteosarcoma: use of MR imaging and MR spectroscopy in clinical decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Musculoskeletal neoplasms after intraarterial chemotherapy: correlation of MR images with pathologic specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

MR imaging of edema accompanying benign and malignant bone tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Hemorrhage simulating tumor growth in malignant fibrous histiocytoma at MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

The biophysical basis of tissue contrast in extracranial MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

Dynamic, gadolinium-enhanced MR imaging to monitor tumor response to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983135-6

10.1016/S0009-9260(05)83135-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7789022%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference